Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: diabetes mellitus

Cardiorenal effects of newer antidiabetic agents

Athanasia K. Papazafiropoulou, Elias Georgopoulos, Stavros Antonopoulos

Evaluation of Different Scores to Predict Non-alcoholic Fatty Liver Disease in patients with type 2 diabetes

Angeliki M Angelidi, Athanasia Papazafiropoulou, Eleni-Margarita Tzouganatou, Konstantina Anagnostopoulou, Vasilis Velissaris, Vangelis Markakis, Ekaterini Vagena, Αndreas Melidonis

The cardioprotective effects of flavonoids: a focus on classic cardiovascular risk factors

Eleni Kokkou, Nikoleta Bozini, Maria Lavda, Konstantinos Mourouzis, Gerasimos Siasos

Lipid control in patients with and without type 2 Diabetes Mellitus (T2DM). The experience of a special unit of a second grade hospital

Stamatis S Papadatos, Adamantios Bourdakis

Naltrexone ER/Bupropion ER for the treatment of obesity

Eleni Pappa, Theodosios D Filippatos, Moses S Elisaf

SGLT2 inhibitors: what to expect in the future

Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf

The use of dapagliflozin in the treatment of type 2 diabetes mellitus

Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf

Cardiovascular risk factors and longevity

M. Kouris, A. Konstantinou, M. Kouri, A. Stavrou, E. Bilianou, S. Fousas

Novel roles of vitamin D in pathogenesis of cardiovascular disease

Stefania Makariou, Evangelos N Liberopoulos, Anna Challa

CURRENT ISSUE

Empagliflozin in mice fed on a fast-food diet: Preliminary biochemical data
The role of epidemiology research in economic evaluation for Health Technology Assessment
Type 1 diabetes mellitus and cardiovascular risk: A short review
Health literacy in relation to health outcomes in hypertension: A systematic review
A Collection of Position Statements and Opinions on e-cigarette use and cardiovascular disease: On behalf of the Working Group on Epidemiology of the Hellenic Atherosclerosis Society

Keywords

acute coronary syndrome (4) Arterial hypertension (3) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (22) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (5) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (4) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (7) metabolic syndrome (7) mortality (7) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (7) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombosis (4) treatment (5) type 2 diabetes (3) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme